Current Issue

View Larger Image

Past Issues Adlink Subscription Visit Our Publisher

ADVERTISEMENT



Top Keywords




GEN podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

"KITCHEN CHEMISTRY" FOR COMPLEX PHARMACEUTICAL SYNTHESIS

12/17/2009

- Interview with Jin-Quan Yu, Ph.D., Associate Professor, Department of Chemistry, Scripps Research Institute

A team at The Scripps Research Institute reports that it has made major strides in solving a problem that has been plaguing chemists for many years: how best to break carbon-hydrogen bonds and then to create new bonds to join molecules together. This problem is of great importance to the pharmaceutical industry, which currently relies on a method to accomplish this feat that is relatively inefficient and sometimes difficult to perform.

The research was published online on November 26, 2009, in Science Express.

During this week's podcast, team leader Dr. Jin-Quan Yu provides additional details on the pharmaceutical industry's interest in carbon-hydrogen bonds. He discusses the advantages, and the downside, of relying on the "Mizoroki-Heck" reaction, which is currently used by chemists and pharmaceutical scientists to forge carbon-carbon bonds in place of carbon-hydrogen bonds.

Dr. Yu goes on to describe the new technique his team developed to break carbon-hydrogen bonds more efficiently and economically and how it might impact the discovery, development, and manufacture of novel drug compounds.
Jin-Quan Yu, Ph.D. is an Associate Professor in the Department of Chemistry at the Scripps Research Institute.

Related content

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe
e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
Confirm Email
First Name
Last Name
Organization
E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Funding Early-Stage Companies

How much do you think newly established funds will succeed in helping startups?

Suggest a Poll